On Thursday, Shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY), subtract -0.18% and closed at $61.08 in the last trading session. The last trading range of the stock ranges between $60.85 and $62.17. DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), The Dental Solutions CompanyTM, recently declared its financial results for the three months ended September 30, 2016.
Third Quarter 2016 Financial Results
Stated net sales of $954.2 million raised 47.0% contrast to $648.9 million in the third quarter of 2015. For the three month period ended September 30, 2016, sales of the combined businesses1 grew 0.4% at constant currency exchange rates and internal growth2 was flat.
On a geographic basis, U.S. stated net sales, apart from precious metals, of $334.2 million raised 33.9% contrast to $249.5 million in the third quarter of 2015. Sales of the combined businesses1 declined 3.1% on a constant currency basis with internal growth down 3.2% during the three month period ended September 30, 20162.
Stated net sales in Europe, apart from precious metals, raised 41.3% to $348.3 million contrast to $246.5 million in the third quarter of 2015. Sales of the combined businesses1 grew 1.6% on a constant currency basis with internal growth of 1.2% during the three month period ended September 30, 20162.
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), jumped 9.76% and closed at $78.72 in the last trading session. The last trading range of the stock ranges between $72.04 and $80.96. The company’s Market capitalization is $3.64 Billion with the total Outstanding Shares of 40.86 million. Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, will present at the following shareholder conferences:
Shalini Sharp, the company’s Chief Financial Officer, will present at the Credit Suisse 25th Annual Healthcare Conference on Tuesday, November 8, 2016 at 2:30pm MT in Scottsdale, AZ.
Tom Kassberg, the company’s Chief Business Officer, will present at the Stifel 2016 Healthcare Conference on Tuesday, November 15, 2016 at 1:30pm ET in New York, NY.
Jacobs Engineering Group Inc (NYSE:JEC), jumped 1.78% and closed at $55.89 in the last trading session. The last trading range of the stock ranges between $55.29 and $56.69. During the 52-week trading session the minimum price at which share price traded, registered at $34.76 and reached to max level of $56.69. Following a string of recent contract wins, Jacobs Engineering Group Inc. has reinforced its status as one of the world’s leading transport infrastructure service providers.
The success follows the Australian Government’s recent commitment to infrastructure investment, which aims to create more livable and productive communities through well-planned, safer and more efficient transport networks. As part of the Smart Cities Plan to build a more prosperous and innovative nation, the government is investing more than $3.4 billion in urban rail projects across the country.
“Australia’s infrastructure market is particularly buoyant right now,” said Jacobs Senior Vice President Buildings and Infrastructure Patrick Hill. “This is driven by increases in population, congestion, and demand for livable cities. Our recent appointment on a number of major projects confirms our expertise in addressing these and related transport infrastructure challenges.”